Reverse takeover

SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, HWCC, WIFI, and NTWN Shareholders About Its Ongoing Investigations

Friday, May 7, 2021 - 10:18pm

Under the terms of the agreement, MDCA\'s shareholders will receive just 26% of the common equity of the post-transaction entity.

Key Points: 
  • Under the terms of the agreement, MDCA\'s shareholders will receive just 26% of the common equity of the post-transaction entity.
  • Under the terms of the merger agreement, HWCC shareholders will receive $5.30 in cash for each share of HWCC common stock that they hold.
  • Under the terms of the merger agreement, WIFIshareholders will receive $14.00 in cash for each WIFI share that they own.
  • Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.

Wondr Gaming Corp. Announces Completion of Reverse Takeover Transaction

Tuesday, May 4, 2021 - 1:06am

b'Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - May 3, 2021) - Wondr Gaming Corp. (formerly Transglobe Internet and Telecom Co., Ltd.) (the "Company") and Wondr Gaming Corporation (formerly, 1Wondr Gaming Corporation) ("Wondr") are pleased to announce the completion of the Company\'s previously announced reverse takeover transaction (the "Transaction") pursuant to which the Company acquired all of the issued and outstanding common shares of Wondr in exchange for shares of the Company, as further detailed below.

Key Points: 
  • b'Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - May 3, 2021) - Wondr Gaming Corp. (formerly Transglobe Internet and Telecom Co., Ltd.) (the "Company") and Wondr Gaming Corporation (formerly, 1Wondr Gaming Corporation) ("Wondr") are pleased to announce the completion of the Company\'s previously announced reverse takeover transaction (the "Transaction") pursuant to which the Company acquired all of the issued and outstanding common shares of Wondr in exchange for shares of the Company, as further detailed below.
  • Each Subscription Receipt was automatically converted into common shares and warrants of Wondr prior to completion of the Transaction.
  • The forward\xe2\x80\x90looking statements and information are based on certain key expectations and assumptions made by management of the Company.
  • Since forward\xe2\x80\x90looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

Yooma Wellness Announces Financial Results of Yooma Corp. for the 2020 Financial Year

Saturday, May 1, 2021 - 1:11am

b'TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM), a\xc2\xa0Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has filed the annual financial statements (the "Financial Statements") for one of its predecessor companies, Yooma Corp., for the financial period from January 1, 2020 to December 31, 2020 (the "Reporting Period").

Key Points: 
  • b'TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma") (CSE: YOOM), a\xc2\xa0Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has filed the annual financial statements (the "Financial Statements") for one of its predecessor companies, Yooma Corp., for the financial period from January 1, 2020 to December 31, 2020 (the "Reporting Period").
  • Yooma was formed by amalgamation on February 10, 2021, when Yooma Corp. completed a reverse takeover of Globalive Technology Inc. ("GTI").
  • Yooma and GTI worked diligently throughout the Reporting Period to negotiate definitive agreements and satisfy the conditions to completing the reverse takeover transaction.
  • In total, the consideration paid by Yooma in connection with the Merger amounted to\xc2\xa0US$25,000,000, which was satisfied by the issuance of 23,320,896 common shares of Yooma at a price of\xc2\xa0CAD$1.34.\nKey financial highlights during the Reporting Period included the following:\n'

SHAREHOLDER ALERT: WeissLaw LLP Reminds CBAN, WRI, PPD, and VKIN Shareholders About Its Ongoing Investigations

Thursday, April 29, 2021 - 10:59pm

Under the terms of the merger agreement, PPD shareholders will receive $47.50 in cash for each share of PPD common stock that they hold.

Key Points: 
  • Under the terms of the merger agreement, PPD shareholders will receive $47.50 in cash for each share of PPD common stock that they hold.
  • Under the terms of the merger agreement, which is structured as a reverse merger, CEI will issue newly-issued shares of common stock in exchange for the balance of VKIN common stock on a one-for-one basis.
  • CEI currently owns approximately 62% of VKIN\'s issued and outstanding common shares.
  • If you own VKINshares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/vkin/\nView original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-r...\n'

Small Pharma Completes Reverse Take-Over Transaction

Thursday, April 29, 2021 - 3:51pm

The Reverse Takeover constitutes the Company\xe2\x80\x99s Qualifying Transaction (as defined by Policy 2.4 of the TSX Venture Exchange (the \xe2\x80\x9cTSXV\xe2\x80\x9d)) and was completed according to the terms of an offer agreement dated March 25, 2021 (the \xe2\x80\x9cOffer Agreement\xe2\x80\x9d), pursuant to which the Company made an offer to the Small Pharma securityholders to purchase all of the ordinary shares in the capital of Small Pharma (the \xe2\x80\x9cSmall Pharma Shares\xe2\x80\x9d) currently held or to be held prior to the closing of the Reverse Takeover at an exchange ratio as set out in the Offer Agreement.\nUnless otherwise indicated, all currency references are to Canadian dollars.\nPeter Rands, CEO of the Company, said: \xe2\x80\x9cThe closing of this reverse takeover is a major step for Small Pharma to becoming a fully listed company on the TSX Venture Exchange.

Key Points: 
  • The Reverse Takeover constitutes the Company\xe2\x80\x99s Qualifying Transaction (as defined by Policy 2.4 of the TSX Venture Exchange (the \xe2\x80\x9cTSXV\xe2\x80\x9d)) and was completed according to the terms of an offer agreement dated March 25, 2021 (the \xe2\x80\x9cOffer Agreement\xe2\x80\x9d), pursuant to which the Company made an offer to the Small Pharma securityholders to purchase all of the ordinary shares in the capital of Small Pharma (the \xe2\x80\x9cSmall Pharma Shares\xe2\x80\x9d) currently held or to be held prior to the closing of the Reverse Takeover at an exchange ratio as set out in the Offer Agreement.\nUnless otherwise indicated, all currency references are to Canadian dollars.\nPeter Rands, CEO of the Company, said: \xe2\x80\x9cThe closing of this reverse takeover is a major step for Small Pharma to becoming a fully listed company on the TSX Venture Exchange.
  • Canaccord Genuity Corp. and Eight Capital, as co-lead agents together with Haywood Securities Inc. (collectively, the \xe2\x80\x9cAgents\xe2\x80\x9d), acted as agents in relation to the brokered private placement.
  • A further press release will be issued in advance of the commencement of trading.\nIn connection with the Reverse Takeover, the Company issued a total of 315,496,144 Common Shares, including 255,079,477 in exchange for Small Pharma Shares and 60,416,667 in exchange for Finco Shares.
  • Additional information related to the Company\xe2\x80\x99s business and the Reverse Takeover (including the members of the management team and board of directors listed above) is available in the Filing Statement.\nAird & Berlis LLP acted as Canadian legal counsel to Small Pharma with Memery Crystal LLP acting as UK legal counsel to Small Pharma.

InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Gregory Wagner, CEO of RYAH Group Inc.

Thursday, April 29, 2021 - 1:17pm

\xe2\x80\x9cIt was quite a long journey through a reverse takeover (RTO) transaction.

Key Points: 
  • \xe2\x80\x9cIt was quite a long journey through a reverse takeover (RTO) transaction.
  • I like to think of the company as a pioneering IoT device and digital care platform.
  • Those clinical trials or formulation partners will fill our device cartridges with their medicine and distribute the product,\xe2\x80\x9d he added.
  • These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.\n"

SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, WIFI, FLIR, and NTWN Shareholders About Its Ongoing Investigations

Friday, April 23, 2021 - 8:47pm

Under the terms of the agreement, MDCA\'s shareholders will receive just 26% of the common equity of the post-transaction entity.

Key Points: 
  • Under the terms of the agreement, MDCA\'s shareholders will receive just 26% of the common equity of the post-transaction entity.
  • Under the terms of the merger agreement, WIFIshareholders will receive $14.00 in cash for each WIFI share that they own.
  • Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.
  • If you own NTWN shares and wish to discuss this investigation or your rights, please call or visit our website: https://weisslawllp.com/news/ntwn/\nView original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-r...\n'

W Technologies, Inc. Signs Letter of Intent to Acquire 100% Curisin Corp through a Merger with a Subsidiary of W Technologies, Inc.

Thursday, April 15, 2021 - 3:00pm

b'BEVERLY HILLS, Calif., April 15, 2021 /PRNewswire/ --W Technologies, Inc., ("W Tech or the Company"), (OTC: WTCG)announced today that it signed a non-binding letter of intent to acquire Curisin Corp. through a reverse merger with a wholly-owned subsidiary of the Company.

Key Points: 
  • b'BEVERLY HILLS, Calif., April 15, 2021 /PRNewswire/ --W Technologies, Inc., ("W Tech or the Company"), (OTC: WTCG)announced today that it signed a non-binding letter of intent to acquire Curisin Corp. through a reverse merger with a wholly-owned subsidiary of the Company.
  • Curisin recently acquired the assets of an accredited digital healthcare platform in India that will form the foundation for building possibly one of the largest blockchain healthcare platforms in the world.
  • Any such forward-looking information is expressly qualified in its entirety by this cautionary statement.
  • Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward look information.

SHAREHOLDER ALERT: WeissLaw LLP Reminds FLIR, NTWN, OBLN, and GLUU Shareholders About Its Ongoing Investigations

Friday, April 9, 2021 - 8:07pm

Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.

Key Points: 
  • Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.
  • Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc.
  • Under the terms of the agreement, the Company's shareholders will receive $12.50 in cash for each share of GLUU common stock that they hold.
  • If you own GLUUshares and wish to discuss this investigation or your rights, please call or visit our website: http://weisslawllp.com/gluu/
    View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-r...

Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments

Wednesday, March 31, 2021 - 1:47pm

Yumanity made important scientific and operational progress throughout the course of the last year, said Richard Peters, M.D., Ph.D., President, Chief Executive Officer and Director of Yumanity.

Key Points: 
  • Yumanity made important scientific and operational progress throughout the course of the last year, said Richard Peters, M.D., Ph.D., President, Chief Executive Officer and Director of Yumanity.
  • Completed reverse merger with Proteostasis Therapeutics, Inc. on December 22, 2020 and commenced trading on the Nasdaq Capital Market on December 23, 2020, under the ticker symbol YMTX.
  • Closed $33.6 million common stock private investment in public equity (PIPE) transaction concurrently with the closing of the reverse merger.
  • General and administrative expenses: General and administrative expenses were $11.9 million and $7.1 million for the years ended December 31, 2020 and 2019.